Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BNTX Stock — BioNTech SE
BioNTech SE (BNTX)
Updated October 16, 2026.
BNTX is a Stock. Total return is 524.1% over the past 7 years, 336.4 points ahead of SPY at 187.7%.
BioNTech SE is a German biopharmaceutical company that develops and commercializes immunotherapies, including mRNA vaccines and oncology drugs. The company gained prominence through its SARS-CoV-2 vaccine and maintains a pipeline of cancer treatments and infectious disease candidates across various clinical trial phases. BioNTech does not currently distribute to shareholders on a regular basis, though it has made special distributions in the past that should not be expected to recur.
BNTX dividend yield and income
Price as of 2026-10-16.
The ex-dividend date is 06/02/2022. The payment date is 06/17/2022.
| Ex-date | Amount | Change from previous payment |
|---|---|---|
| 2022-06-02 | $2.111 | — |
| 2022 total | $2.111 | — |
BNTX performance versus SPY
Price and return data through 2026-10-16.
Total return is 524.1% over the past 7 years, 336.4 points ahead of SPY at 187.7%. Over the past year its total return — price change plus distributions reinvested — is -16.5%. Its deepest 1-year drawdown was 29.7%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -8.5% | — |
| 3M | -4.2% | — |
| 6M | -14.1% | — |
| YTD | -7.9% | — |
| 1Y | -16.5% | — |
| 2Y CAGR | — | -13.70% |
| 3Y CAGR | — | -3.30% |
| 5Y CAGR | — | -18.50% |
| Since inception (7 years) | 524.1% | 29.80% |
BNTX key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 10/10/2019
- Distribution frequency
- None
- Last close
- $87.71 (as of 2026-10-16)
- Market cap
- $22,033,134,942
- Average volume
- 1104149.0
- Ex-dividend date
- 06/02/2022
- Payment date
- 06/17/2022
- Beta
- 1.252
- Payout ratio
- 0.0%
- Forward P/E
- 7.0373
- EPS
- $-7.83
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BNTX risks and drawbacks
The deepest 1-year drawdown on record here is 29.7%.
Who may consider BNTX — and who may not
It is a weaker fit for investors who need monthly cash flow (BNTX does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on BNTX
Frequently asked questions
Does BNTX pay monthly?
No. BNTX does not currently distribute.
When does BNTX pay a dividend?
BNTX does not currently distribute. The ex-dividend date is 06/02/2022. The payment date is 06/17/2022.
How has BNTX performed?
Total return is 524.1% over the past 7 years, 336.4 points ahead of SPY at 187.7%. Over the past year its total return — price change plus distributions reinvested — is -16.5%. Its deepest 1-year drawdown was 29.7%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.